Targeting Endoplasmic Reticulum Stress in Human Hypertension

NCT06025630 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Hypertension

Interventions

DRUG: TUDCA
DRUG: Placebo

Sponsor

University of North Texas Health Science Center